Biotech · Public company · Houston, TX, US
FibroBiologics, Inc.
Ticker FBLG · SEC CIK 0001958777
Track this companyFree. Adds FibroBiologics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
SEC filings12
- 8-K · 8-KSEC EDGAR · filed Oct 8, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 18, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 15, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 24, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Jul 31, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 24, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jul 9, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 29, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 23, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 6, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 5, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 1, 2026 · fetched Nov 12, 2026
NIH awards1
- Development of a Novel Therapeutic Agent for Skin FibrosisFiscal year 2024 · $306.5KNIH RePORTER 1R41AR084935-01 · fetched Nov 12, 2026